T Schilling1, R Bekeredjian, A Haverich, H A Katus. 1. Klinik für Herz-, Thorax-, Transplantations- und Gefässchirurgie, Medizinische Hochschule, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland. schilling.tobias@mh-hannover.de
Abstract
UNLABELLED: Increasingly complex techniques in cardiovascular medicine lead to a competitive partnership between cardiology and cardiac surgery. Common challenges will arise in the fields of coronary heart disease, heart valves, heart failure and rhythm therapy. For instance, coronary revascularization in acute myocardial infarction is no longer considered to exclusively be an interventional option. In comparison, the implantation of heart valves is increasingly carried out by cardiologists using interventional techniques. The latest designs of sutureless valves try to combine the benefits of conventional and transcatheter heart valves. Heart failure is the most common reason for hospital admission and thus an important therapeutic target for cardiology and cardiac surgery. New approaches in diagnostics, heart assist devices and cellular therapy meet this challenge. CONCLUSION: In the future only a sensitive and transparent collaboration across transsectoral borders will offer optimal therapy in cardiovascular medicine.
UNLABELLED: Increasingly complex techniques in cardiovascular medicine lead to a competitive partnership between cardiology and cardiac surgery. Common challenges will arise in the fields of coronary heart disease, heart valves, heart failure and rhythm therapy. For instance, coronary revascularization in acute myocardial infarction is no longer considered to exclusively be an interventional option. In comparison, the implantation of heart valves is increasingly carried out by cardiologists using interventional techniques. The latest designs of sutureless valves try to combine the benefits of conventional and transcatheter heart valves. Heart failure is the most common reason for hospital admission and thus an important therapeutic target for cardiology and cardiac surgery. New approaches in diagnostics, heart assist devices and cellular therapy meet this challenge. CONCLUSION: In the future only a sensitive and transparent collaboration across transsectoral borders will offer optimal therapy in cardiovascular medicine.
Authors: Jay Ritzema; Richard Troughton; Iain Melton; Ian Crozier; Robert Doughty; Henry Krum; Anthony Walton; Philip Adamson; Saibal Kar; Prediman K Shah; Mark Richards; Neal L Eigler; James S Whiting; Garrie J Haas; J Thomas Heywood; Christopher M Frampton; William T Abraham Journal: Circulation Date: 2010-02-22 Impact factor: 29.690
Authors: Hugo E Verdejo; Pablo F Castro; Roberto Concepción; Marcela A Ferrada; Mario A Alfaro; Milton E Alcaíno; Carlos C Deck; Robert C Bourge Journal: J Am Coll Cardiol Date: 2007-12-18 Impact factor: 24.094
Authors: N Rodriguez-Losada; J M Garcia-Pinilla; M F Jimenez-Navarro; F J Gonzalez Journal: Cell Mol Biol (Noisy-le-grand) Date: 2008-10-26 Impact factor: 1.770
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Jay Ritzema; Iain C Melton; A Mark Richards; Ian G Crozier; Chris Frampton; Robert N Doughty; James Whiting; Saibal Kar; Neal Eigler; Henry Krum; William T Abraham; Richard W Troughton Journal: Circulation Date: 2007-12-03 Impact factor: 29.690